Reborna Biosciences

    OverviewSuggest Edit

    Reborna Biosciences is a company that provides drugs acting on ribonucleic acid (RNA) to patients suffering from rare genetic diseases. It develops drug discovery technology enabling low-molecular compounds to target RNA.
    TypePrivate
    Founded2018
    Websiterebornabiosciences.com

    Latest Updates

    Cybersecurity ratingAMore

    Reborna Biosciences Financials and Metrics

    Summary Metrics

    Founding Date

    2018

    Reborna Biosciences Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    98/100

    SecurityScorecard logo

    Reborna Biosciences Online and Social Media Presence

    Embed Graph

    Reborna Biosciences Frequently Asked Questions

    • When was Reborna Biosciences founded?

      Reborna Biosciences was founded in 2018.

    • Who are Reborna Biosciences competitors?

      Competitors of Reborna Biosciences include Juventas Therapeutics, BioSavita and CRISPR Therapeutics.